| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/28/2009 | CA2212382C Cochleate delivery vehicles |
| 04/23/2009 | WO2009052478A1 Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide |
| 04/23/2009 | WO2009051908A1 Trans-clomiphene for metabolic syndrome |
| 04/23/2009 | WO2009051804A1 Thiazolium compounds for treating or preventing diseases associated with insulin resistance |
| 04/23/2009 | WO2009051786A2 Methods for treating obesity, insulin resistance and inducing satiety |
| 04/23/2009 | WO2009051747A1 Deuterated lorcaserin |
| 04/23/2009 | WO2009051706A2 Peptide compounds for treating obesity and insulin resistance |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009051119A1 Pyrimidyl indoline compound |
| 04/23/2009 | WO2009050523A1 Azetidinyl g-protein coupled receptor agonists |
| 04/23/2009 | WO2009050522A1 Azetidinyl g-protein coupled receptor agonists |
| 04/23/2009 | WO2009050348A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | WO2009050318A1 Pyrazole derivatives of fatty acid amides as ppar-alpha receptor specific activators, preparation method thereof and use of same |
| 04/23/2009 | WO2009050252A1 Novel sulfamate compounds for medical use |
| 04/23/2009 | WO2009050201A2 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 04/23/2009 | WO2009050200A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
| 04/23/2009 | WO2009050199A1 Purine derivatives as adenosine al receptor ligands |
| 04/23/2009 | WO2009049742A2 Use of melanotrophin-potentiating factor as a therapeutic agent |
| 04/23/2009 | WO2009049731A1 Imidazo[1,2-a]pyrimidine derivatives for treating diseases such as diabetes |
| 04/23/2009 | WO2009049422A1 Compositions and methods for enhancing enzyme activity in gaucher, gm1 -gangliosidosis/morquio b disease. and parkinson's disease |
| 04/23/2009 | WO2009049421A1 Compositions and methods for enhancing enzyme activity in gaucher, gm1-gangliosidosis/morquio b disease, and parkinson's disease |
| 04/23/2009 | WO2009028989A3 Overweight treatment method |
| 04/23/2009 | WO2009018511A3 Alpha7 nachr agonists for treating or preventing metabolic disorders |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105342 Pufa supplements |
| 04/23/2009 | US20090105335 from high glyceride content polyunsaturated oils, including fish oils; saponification of fatty acid with mono or divalent metal hydroxide (potassium, calcium, copper, magnesium); antioxidant stabilizing oil; free flowing; storage stable; nutritional supplement; pet food |
| 04/23/2009 | US20090105327 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds |
| 04/23/2009 | US20090105310 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use |
| 04/23/2009 | US20090105305 Therapeutic Agents - 550 |
| 04/23/2009 | US20090105293 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105289 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds |
| 04/23/2009 | US20090105284 Aminocyclohexanes as Dipeptidyl Peptidase-IV for the Treatment or Prevention of Diabetes |
| 04/23/2009 | US20090105281 Methods of treating inflammation |
| 04/23/2009 | US20090105278 Selective inhibitors of human corticosteroid syntheses |
| 04/23/2009 | US20090105273 Diacylglycerol Acyltransferase Inhibitors |
| 04/23/2009 | US20090105265 Pharmaceutical Compositions of Combinations of Dipeptidyl Peptidase-4 Inhibitors With Metformin |
| 04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 04/23/2009 | US20090105255 Glucokinase activators |
| 04/23/2009 | US20090105243 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 04/23/2009 | US20090105229 Purine derivatives as kinase inhibitors |
| 04/23/2009 | US20090105217 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
| 04/23/2009 | US20090105204 Therapeutic Uses for Aminosterol Compounds |
| 04/23/2009 | US20090105192 Glycosaminoglycans derived from k5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation |
| 04/23/2009 | US20090105165 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 04/23/2009 | US20090105164 Substituted indole-o-glucosides |
| 04/23/2009 | US20090105162 Substituted fused heterocyclic c-glycosides |
| 04/23/2009 | US20090105124 Heterocyclic modulators of tgr5 |
| 04/23/2009 | US20090105121 Insulin Derivative |
| 04/23/2009 | US20090104697 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells |
| 04/23/2009 | US20090104270 Film delivery system for tetrahydrolipstatin |
| 04/23/2009 | US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/23/2009 | DE102007048716A1 Imidazo[1,2-a]pyrimidinderivate Imidazo [1,2-a] pyrimidine derivatives |
| 04/23/2009 | CA2806526A1 Trans-clomiphen for type 2 diabetes |
| 04/23/2009 | CA2703039A1 Purine derivatives as adenosine a1 receptor ligands |
| 04/23/2009 | CA2702950A1 Methods and compounds for modulating cannabinoid activity |
| 04/23/2009 | CA2702710A1 Trans-clomiphene for metabolic syndrome |
| 04/23/2009 | CA2702577A1 Method for increasing performance of offspring |
| 04/23/2009 | CA2702442A1 Peptide compounds for treating obesity and insulin resistance |
| 04/23/2009 | CA2702281A1 Imidazo[1,2-a]pyrimidine derivatives |
| 04/23/2009 | CA2700568A1 Novel sulfamate compounds for medical use |
| 04/23/2009 | CA2699075A1 Use of a peptide as a therapeutic agent |
| 04/23/2009 | CA2694994A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/22/2009 | EP2050750A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050741A1 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 04/22/2009 | EP2050739A1 Quinazoline derivative |
| 04/22/2009 | EP2050460A1 PYY and agonists thereof for modification of feeding behaviour |
| 04/22/2009 | EP2050456A1 Tablet |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2050448A1 Oral disintegrating tablet having masked bitter taste and method for production thereof |
| 04/22/2009 | EP2050445A2 Pharmaceutical composition of phenofibrate with high bioavailability and method for preparing same |
| 04/22/2009 | EP2050444A1 Fatigue-reducing agent |
| 04/22/2009 | EP2049544A2 Purinone derivatives as hm74a agonists |
| 04/22/2009 | EP2049525A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 04/22/2009 | EP2049523A1 Modulators of metabolism and the treatment of disorders related thereto |
| 04/22/2009 | EP2049513A1 Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/22/2009 | EP2049503A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| 04/22/2009 | EP2049481A2 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 04/22/2009 | EP2049479A2 Polymorphs of atorvastatin sodium and magnesium salts |
| 04/22/2009 | EP2049475A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/22/2009 | EP2049149A2 Pegylated extended insulins |
| 04/22/2009 | EP2049133A2 New eucalyptus extract, method of preparation and therapeutic uses thereof |
| 04/22/2009 | EP2049110A2 Bridged diazepan orexin receptor antagonists |
| 04/22/2009 | EP2049107A2 Substituted imidazolone derivatives, preparation and uses |
| 04/22/2009 | EP2048969A1 Fractions of whey permeate and its use for the prevention and therapy of type 2 diabetes and the metabolic syndrome |
| 04/22/2009 | EP2002842A9 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator |
| 04/22/2009 | EP2002832A9 Composition containing lignan compound |
| 04/22/2009 | EP1718632B1 Pyrimidine derivatives as orexin receptor antagonists |
| 04/22/2009 | EP1585518A4 Peptide deformylase inhibitors |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | EP1505974B1 Use of compounds that are effective as selective opiate receptor modulators |
| 04/22/2009 | EP1425266B1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments |
| 04/22/2009 | EP1364069B1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 04/22/2009 | EP1334721B1 Nateglinide-containing hydrophilic drug preparations |
| 04/22/2009 | EP1285908B9 Substituted phenylpropionic acid derivatives |
| 04/22/2009 | EP1049459B1 Oral liquid compositions |
| 04/22/2009 | EP0869775B1 Dietary fiber inulin delivery system |
| 04/22/2009 | CN101415716A Condensed imidazole derivatives as aldosterone synthase inhibitors |
| 04/22/2009 | CN101415706A Azolopyridin-3-one derivatives as inhibitors of endothelial lipase |